Treatment of Helicobacter pylori: An overview

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 3, 2000, Pages 1-6

  Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE;

ADENOCARCINOMA; B CELL LYMPHOMA; CANCER RISK; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MENETRIER DISEASE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0033783904     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00394.x     Document Type: Conference Paper

References (37)

1. Helicobacter pylori. Causal agent in peptic ulcer disease? Working Party Report to the World Congresses of Gastroenterology
2. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
3. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage
4. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
5. Absorption of drugs from the stomach II
6. Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue after eradication of Helicobacter pylori
7. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy
8. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations
9. Lymphocytic gastritis: Relationship to Campylobacter pylori infection
10. Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis
11. Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach
12. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia
13. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double-blind placebo controlled trial with 12 months' follow up
14. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia
15. Effect of omeprazole in functional dyspepsia: A double-blind, randomized, placebo-controlled study
16. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials
17. Treatment of functional dyspepsia (FD) with omeprazole and ranitidine
18. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia
19. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
20. Does cure of Helicobacter pylori infection induce heartburn?
21. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
22. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer
23. Omeprazole: Helicobacter pylori makes thee greater yet
24. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial
25. Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomized double blind study
26. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux
27. H pylori screening and treatment reduces dyspepsia in the community
28. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
29. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease
30. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety
31. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety
32. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole
33. 2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients
34. Helicobacter gastroduodenitis: A serious infectious disease
35. Population H. pylori screening and treatment reduces dyspepsia costs
36. Evaluation of treatment regimens to cure Helicobacter pylori infection - A meta-analysis